Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-25

FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Tenofovir disoproxil fumarate by Aurobindo Pharma Limited. This approval relates to a generic product used to treat …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

SUPPL AP for TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR DISOPROXIL FUMARATE)